Does mitotic rate predict sentinel lymph node metastasis or survival in patients with intermediate and thick melanoma?

American Journal of Surgery

Volumn 200, Issue 6, 2010, Pages 759-764

  Roach, Brent A ^a   Burton, Alison L ^a   Mays, Michael P ^a   Ginter, Brooke A ^a   Martin, Robert C G ^a   Stromberg, Arnold J ^b   Hagendoorn, Lee ^c   McMasters, Kelly M ^a   Scoggins, Charles R ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c Advertek Inc   (United States)

Author keywords

Melanoma; Mitotic rate; Sentinel lymph node; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SIZE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MITOSIS; MITOSIS RATE; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MITOTIC INDEX; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 78650189736     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2010.07.037     Document Type: Article

References (25)

1. A.B. Francken, H.M. Shaw, and J.F. Thompson The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up Ann Surg Oncol 11 2004 426 433
2. R.L. Barnhill, J.A. Fine, and G.C. Roush Predicting five-year outcome for patients with cutaneous melanoma in a population-based study Cancer 78 1996 427 432
3. S. Retsas, K. Henry, and M.Q. Mohammed Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patients Eur J Cancer 38 2002 511 516
4. M.F. Azzola, H.M. Shaw, and J.F. Thompson Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center Cancer 97 2003 1488 1498
5. M.G. Attis, and R.T. Vollmer Mitotic rate in melanoma: a reexamination Am J Clin Pathol 127 2007 380 384
6. E. Nagore, V. Oliver, and R. Botella-Estrada Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis Melanoma Res 15 2005 169 177
7. E. Zettersten, R.W. Sagebiel, and J.R. Miller III Prognostic factors in patients with thick cutaneous melanoma (>4 mm) Cancer 94 2002 1049 1056
8. K.M. McMasters The Sunbelt Melanoma Trial Ann Surg Oncol 8 2001 41S 43S
9. K.M. McMasters, D.S. Reintgen, and M.I. Ross Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol 8 2001 192 197
10. K.M. McMasters, R.D. Noyes, and D.S. Reintgen Lessons learned from the Sunbelt Melanoma Trial J Surg Oncol 86 2004 212 223
11. A.N. Crowson, C.M. Magro, and M.C. Mihm Prognosticators of melanoma, the melanoma report, and the sentinel lymph node Mod Pathol 19 Suppl 2 2006 S71 S87
12. M.J. Payette, M. Katz III, and J.M. Grant-Kels Melanoma prognostic factors found in the dermatopathology report Clin Dermatol 27 2009 53 74
13. G.Q. Phan, J.L. Messina, and V.K. Sondak Sentinel lymph node biopsy for melanoma: indications and rationale Cancer Control 16 2009 234 239
14. J.L. Zapas, H.C. Coley, and S.L. Beam The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy J Am Coll Surg 197 2003 403 407
15. G.C. Karakousis, P.A. Gimotty, and J.D. Botbyl Predictors of regional nodal disease in patients with thin melanomas Ann Surg Oncol 13 2006 533 541
16. M.F. Kalady, R.R. White, and J.L. Johnson Thin melanomas: predictive lethal characteristics from a 30-year clinical experience Ann Surg 238 2003 528 535
17. V.K. Sondak, J.M. Taylor, and M.S. Sabel Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model Ann Surg Oncol 11 2004 247 258
18. P.A. Gimotty, D. Guerry, and M.E. Ming Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging J Clin Oncol 22 2004 3668 3676
19. S.B. Kesmodel, G.C. Karakousis, and J.D. Botbyl Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas Ann Surg Oncol 12 2005 449 458
20. A.A. Santillan, J.L. Messina, and S.S. Marzban Pathology review of thin melanoma and melanoma in situ in a multidisciplinary melanoma clinic: impact on treatment decisions J Clin Oncol 28 2010 481 486
21. A. Spatz, H.M. Shaw, and K.A. Crotty Analysis of histopathological factors associated with prolonged survival of 10 years or more for patients with thick melanomas (>5 mm) Histopathology 33 1998 406 413
22. C.K. Chang, I.A. Jacobs, and E. Theodosiou Thick melanoma in the elderly Am Surg 69 2003 988 993
23. B.S. Cherpelis, F. Haddad, and J. Messina Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas J Am Acad Dermatol 44 2001 762 766
24. C.K. Chang, I.A. Jacobs, and V.M. Vizgirda Melanoma in the elderly patient Arch Surg 138 2003 1135 1138
25. I.A. Jacobs, C.K. Chang, and G.I. Salti Role of sentinel lymph node biopsy in patients with thick (>4 mm) primary melanoma Am Surg 70 2004 59 62